Researchers used induced pluripotent stem cells to regenerate damaged corneal cells. Three out of four patients experienced vision improvement after the treatment. The study paves the way for new ...
Its lead product is NeuroNata-R (lenzumestrocel), the world’s first stem cell-based therapy for amyotrophic lateral sclerosis (ALS). NeuroNata-R was approved as an orphan drug for the treatment ...
“And Kelly explained that there were other viable treatments available ... with proteins essential to hair growth. Derived from stem-cell technology, Calecim contains PTT-6, a proprietary ...